111 (YI) Net Income towards Common Stockholders (2017 - 2025)
111 (YI) posted Net Income towards Common Stockholders of -$2.3 million for Q4 2025, down 27.4% sequentially from -$1.8 million in Q3 2025, and up 14.64% YoY from -$2.0 million in Q4 2024.
111 (YI) Net Income towards Common Stockholders (2017 - 2025) Analysis & Trends
111 has reported Net Income towards Common Stockholders for 9 years, with the latest figure at -$2.3 million in Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 14.64% year-over-year to -$2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.3 million (down 3.42% YoY) and the FY2025 annual result came in at -$9.5 million, down 7.03% from the prior year.
- Net Income towards Common Stockholders retreated to -$2.3 million in Q4 2025 per YI's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$1.8 million in Q3 2025 and troughed at -$39.1 million in Q3 2021.
- A 5-year average of -$11.9 million and a median of -$10.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2021 and 2024: Net Income towards Common Stockholders tumbled 144.46% in 2021, then soared 90.83% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$17.5 million in 2021, then climbed by 5.05% to -$16.6 million in 2022, then slumped by 78.6% to -$29.6 million in 2023, then jumped by 90.83% to -$2.7 million in 2024, then gained by 14.64% to -$2.3 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.3 million, -$1.8 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.03 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 776.67 Mn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 400.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 103.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -14.49 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -89.07 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -5.37 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -6.09 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 17,549.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | -2.72 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -1.91 Mn |
| Dec 31, 2023 | -29.63 Mn |
| Sep 30, 2023 | -12.79 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Mar 31, 2023 | -4.63 Mn |
| Dec 31, 2022 | -16.59 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -14.22 Mn |
| Mar 31, 2022 | -17.41 Mn |
| Dec 31, 2021 | -17.47 Mn |
| Sep 30, 2021 | -39.09 Mn |
| Jun 30, 2021 | -24.62 Mn |
| Mar 31, 2021 | -22.38 Mn |